We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.96%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$356B
AUM Growth
+$14.1B
(+4.1%)
Cap. Flow
-$4.79B
Cap. Flow
% of AUM
-1.35%
Top 10 Holdings %
Top 10 Hldgs %
30.2%
Holding
3,385
New
54
Increased
1,101
Reduced
1,417
Closed
52
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SW
Smurfit Westrock
SW
|
+$622M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$269M |
| 3 |
Emerson Electric
EMR
|
+$268M |
| 4 |
ServiceNow
NOW
|
+$252M |
| 5 |
Analog Devices
ADI
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$542M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$499M |
| 3 |
Monster Beverage
MNST
|
+$326M |
| 4 |
NVIDIA
NVDA
|
+$316M |
| 5 |
McDonald's
MCD
|
+$302M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.77% |
| 2 | Financials | 12.09% |
| 3 | Healthcare | 11.08% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Industrials | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Intellia Therapeutics
NTLA
$1.67B
| $7.52M | ﹤0.01% |
365,867
-499,764
| -58% | -$11.5M |
|
1752
Arcutis Biotherapeutics
ARQT
$3.18B
| $7.51M | ﹤0.01% |
807,650
+72,608
| +10% | +$717K |
|
1753
Levi Strauss
LEVI
$9.39B
| $7.5M | ﹤0.01% |
344,188
+2,732
| +0.8% | +$51.7K |
|
1754
Alarm.com
ALRM
$2.85B
| $7.5M | ﹤0.01% |
137,197
| – | – |
|
1755
Green Dot
GDOT
$745M
| $7.5M | ﹤0.01% |
640,432
+1,239
| +0.2% | +$12.9K |
|
1756
St. Joe Company
JOE
$3.83B
| $7.49M | ﹤0.01% |
128,506
+19,782
| +18% | +$1.16M |
|
|
VMEO
1757
DELISTED
Vimeo
VMEO
| $7.49M | ﹤0.01% |
1,483,434
+357,604
| +32% | +$1.62M |
|
1758
Weave Communications
WEAV
$423M
| $7.47M | ﹤0.01% |
583,699
+48,750
| +9% | +$514K |
|
1759
Boston Beer
SAM
$1.92B
| $7.46M | ﹤0.01% |
25,812
-794
| -3% | -$221K |
|
1760
Sonic Automotive
SAH
$2.61B
| $7.45M | ﹤0.01% |
127,449
-31,134
| -20% | -$1.8M |
|
1761
Cohen & Steers
CNS
$4.3B
| $7.42M | ﹤0.01% |
77,376
| – | – |
|
1762
Recursion Pharmaceuticals
RXRX
$1.73B
| $7.41M | ﹤0.01% |
1,123,785
+373,632
| +50% | +$2.68M |
|
1763
TAL Education Group
TAL
$6.87B
| $7.4M | ﹤0.01% |
624,915
-264,606
| -30% | -$2.44M |
|
1764
AngioDynamics
ANGO
$649M
| $7.34M | ﹤0.01% |
943,296
+46,665
| +5% | +$337K |
|
1765
Ennis
EBF
$564M
| $7.33M | ﹤0.01% |
301,502
+73,812
| +32% | +$1.71M |
|
1766
V2X
VVX
$2.65B
| $7.33M | ﹤0.01% |
131,204
+15,002
| +13% | +$765K |
|
1767
Graham Holdings Company
GHC
$5.02B
| $7.31M | ﹤0.01% |
8,893
-138
| -2% | -$105K |
|
1768
Sotera Health
SHC
$5.38B
| $7.31M | ﹤0.01% |
437,516
+6,099
| +1% | +$89.1K |
|
1769
Envista
NVST
$4.52B
| $7.28M | ﹤0.01% |
368,491
-128,273
| -26% | -$2.23M |
|
|
NDVG
1770
DELISTED
Nuveen Dividend Growth ETF
NDVG
| $7.27M | ﹤0.01% |
220,000
| – | – |
|
1771
Alpha Metallurgical Resources
AMR
$1.93B
| $7.27M | ﹤0.01% |
30,776
-334
| -1% | -$85.3K |
|
1772
Cars.com
CARS
$660M
| $7.25M | ﹤0.01% |
432,424
-74,692
| -15% | -$1.36M |
|
1773
Agios Pharmaceuticals
AGIO
$1.93B
| $7.23M | ﹤0.01% |
162,741
-155,200
| -49% | -$7.05M |
|
1774
Ecovyst
ECVT
$1.14B
| $7.22M | ﹤0.01% |
1,054,229
-468,770
| -31% | -$3.57M |
|
1775
Edgewise Therapeutics
EWTX
$4.73B
| $7.22M | ﹤0.01% |
270,406
+27,308
| +11% | +$543K |
|
Similar funds
VFT
Nuveen's Q3 2024 Portfolio in Review
As of Q3 2024, Nuveen held 3,385 positions worth $356B, up 4.1% from $342B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 3.1%. Nuveen opened 54 new positions and exited 52, leaving the 3,385-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q3 2024 buy was Smurfit Westrock: 13,669,531 shares worth $676M.
- Nuveen added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2024, an estimated $269M increase.
- Nuveen's biggest Q3 2024 reduction was Microsoft, cutting an estimated $542M.
- Nuveen fully exited iShares MSCI ACWI ETF in Q3 2024, selling an estimated $114M.
- Nuveen's ten largest holdings make up 30% of its $356B portfolio in Q3 2024.
- Nuveen opened 54 new positions and closed 52 in Q3 2024.
- Nuveen's portfolio value rose 4.1% quarter-over-quarter to $356B.
Based on Nuveen's 13F filing for Q3 2024, filed 14 Nov 2024.